+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Organs-on-chips Market by Material, Product, Technology, End User, Application, Organ Type - Global Forecast to 2030- Product Image
Organs-on-chips Market by Material, Product, Technology, End User, Application, Organ Type - Global Forecast to 2030- Product Image
Sale

Organs-on-chips Market by Material, Product, Technology, End User, Application, Organ Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4857886
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Organs-on-chips Market grew from USD 157.36 million in 2024 to USD 212.96 million in 2025. It is expected to continue growing at a CAGR of 34.38%, reaching USD 926.85 million by 2030.

Reimagining Preclinical Research with Organs-on-Chips

The emergence of organs-on-chips platforms marks a paradigm shift in preclinical research, bridging the gap between cell culture models and human physiology. By integrating microfluidic engineering with living human cells, these platforms replicate tissue-specific microenvironments, enabling dynamic simulation of organ-level functions. This breakthrough addresses longstanding challenges in drug discovery pipelines, where attrition rates remain high and translational fidelity is limited.

Advancements in microfabrication and biomaterials have accelerated the maturation of this technology, drawing interest from pharmaceutical developers, academic institutions, and regulatory agencies. Collaboration across disciplines-biologists, engineers, and data scientists-fosters innovation, while modular designs and scalable manufacturing lower barriers to entry. As a result, organs-on-chips systems are poised to disrupt traditional toxicology testing, disease modeling, and personalized medicine initiatives.

This executive summary outlines the transformative shifts redefining the organs-on-chips landscape, analyzes the implications of new tariff regimes, delves into granular segmentation and regional dynamics, highlights key industry players, and offers actionable recommendations. It culminates in a robust methodology and a forward-looking perspective, equipping decision-makers with the insights needed to harness this disruptive technology.

Key Innovations Reshaping the Organs-on-Chips Ecosystem

Recent years have witnessed seismic innovations that propel organs-on-chips beyond proof-of-concept toward mainstream adoption. Integration of sensor arrays and real-time imaging has enhanced throughput, enabling high-resolution monitoring of cellular responses under dynamic flow conditions. Concurrently, breakthroughs in polymer science have yielded thermoplastics with improved optical clarity and reduced biomolecule absorption, fostering more reliable assay results.

Moreover, the convergence of artificial intelligence and organotypic models has introduced predictive analytics, facilitating in silico extrapolations that accelerate compound screening. Platforms now embrace modular architecture, supporting single-organ and multi-organ configurations that replicate systemic interactions. Partnerships between technology providers and contract research organizations have streamlined validation pathways, while consortium-driven standardization efforts pave the way for regulatory acceptance.

These innovations not only enhance physiological relevance but also drive cost efficiencies, positioning organs-on-chips as a transformative force across the drug development continuum. As the ecosystem matures, interoperability and data harmonization will become critical for scaling applications and unlocking cross-platform insights.

Assessing the Ripple Effects of 2025 US Tariffs on the Sector

The introduction of targeted tariffs on critical imports in 2025 has introduced both headwinds and opportunities for stakeholders in the organs-on-chips domain. With increased duties on certain glass substrates and microfabrication components, manufacturers sourcing materials from abroad have faced elevated input costs. This shift has prompted supply chain recalibration, with some developers exploring domestic suppliers of thermoplastics and PDMS to mitigate the impact.

Conversely, localizing production has catalyzed investments in in-country fabrication facilities, stimulating job creation and technology transfer. Firms adept at leveraging alternative materials with comparable properties have gained a competitive edge, while contract research organizations are renegotiating long-term agreements to secure price stability. On the regulatory front, agencies are engaging with industry consortia to address compliance complexities and streamline customs procedures.

Despite initial cost pressures, these measures have spurred innovation in material science and supply chain resilience. As the market adjusts, executives must balance short-term cost management with long-term strategic partnerships to navigate the evolving trade environment effectively.

Dissecting Market Dynamics Through Core Segmentation Lenses

A comprehensive view of the market emerges through an examination of material, product, technology, end user, application, and organ type lenses. Glass, PDMS, and advanced thermoplastics form the foundational materials that define device performance and manufacturability. Meanwhile, consumables such as microplates and reagents sit alongside core instruments and specialized software to support every phase of organ-on-chip experimentation.

Technological differentiation spans microfluidic chips-encompassing both multi-layer and single-layer designs-as well as single-organ and multi-organ modules that capture inter-tissue crosstalk. Academic laboratories, biotechnology innovators, contract research organizations, global pharmaceutical powerhouses, and specialty pharma enterprises each leverage these platforms to address specific research objectives. On the application front, disease modeling and toxicity testing coexist with increasingly sophisticated drug discovery workflows, including high-throughput screening and lead optimization, as well as personalized medicine initiatives that tailor organotypic assays to patient-derived cells.

Finally, organ specificity drives platform design: gut models probe nutrient absorption and microbiome interactions, heart and lung systems enable cardiotoxicity and respiratory studies, kidney chips assess filtration dynamics, while liver platforms-built on hepatocyte-based or spheroid-based constructs-remain central to metabolism and hepatotoxicity investigations. Through these complementary segmentation lenses, decision-makers can pinpoint unmet needs, align R&D investments, and refine go-to-market strategies.

Unearthing Regional Drivers Behind Platform Adoption Trends

Regional nuances shape the trajectory of organs-on-chips adoption across major geographies. In the Americas, strong government funding and robust biopharmaceutical activity underpin rapid uptake of advanced in vitro models. Collaborative networks between academic centers and industrial R&D hubs accelerate validation studies, and the presence of leading device manufacturers reinforces supply chain stability.

Across Europe, the Middle East, and Africa, regulatory bodies champion alternative testing methods to reduce animal usage, driving demand for physiologically relevant platforms. Initiatives promoting harmonized validation standards have bolstered confidence among pharmaceutical stakeholders, while research consortia in the region facilitate knowledge sharing and joint development projects. Emerging markets within this vast territory are also exploring localized manufacturing to address price sensitivity and ensure material availability.

In Asia-Pacific, a surge in biotech investment and government-backed innovation grants has fueled new entrants into the organs-on-chips arena. Competitive manufacturing ecosystems and a focus on precision medicine have spurred partnerships between regional developers and global pharmaceutical clients. As domestic capacity expands, stakeholders are poised to benefit from cost efficiencies and a diversified supplier base, reinforcing the region’s strategic importance in the global value chain.

Profiling the Powerhouses Fueling This Emerging Industry

The competitive landscape is characterized by a blend of pioneering startups and established technology developers that collectively drive market evolution. Early movers who specialized in microfabrication and cell biology integration have continually refined device ergonomics and assay workflows, securing key collaborations with pharmaceutical sponsors. Meanwhile, mid-tier organizations have focused on scaling consumables production and expanding reagent portfolios to address diverse research needs.

Strategic alliances between software innovators and instrument suppliers have led to seamless data acquisition and cloud-based analytics solutions, enhancing reproducibility and cross-site comparability. Contract research organizations have also carved a niche by offering end-to-end services, from model development to regulatory submission support, cementing their role as vital partners for biopharma firms navigating complex pipelines.

Ongoing investments in commercial scale-up, IP licensing, and targeted mergers and acquisitions underscore the sector’s dynamism. Companies that excel at integrating multidisciplinary expertise, maintaining rigorous quality standards, and anticipating customer pain points are best positioned to capture long-term share in this nascent yet rapidly maturing market.

Strategic Pathways for Leaders to Capitalize on Market Momentum

Industry leaders must adopt a multifaceted strategy that balances innovation, partnerships, and operational excellence. Investing in R&D to develop next-generation materials and sensor integrations will differentiate offerings and drive performance gains. Simultaneously, establishing co-development agreements with academic and contract research organizations can accelerate validation and foster credible use cases.

Supply chain diversification remains critical in light of evolving trade policies; forging relationships with multiple material suppliers and exploring alternative substrates will mitigate cost volatility. Embracing modular, scalable manufacturing approaches supports customization while enabling efficient volume production in response to client demand. Additionally, integrating artificial intelligence and machine learning analytics into platform software can unlock predictive modeling capabilities, enhancing value proposition for end users.

Finally, engaging with regulatory bodies through working groups and consortium initiatives will pave the path toward standardized protocols and broader acceptance. By aligning product roadmaps with end-user workflows and emphasizing data transparency, industry leaders can solidify trust and secure sustainable growth trajectories.

Rigorous Framework Guiding Comprehensive Market Analysis

This analysis employed a structured research framework encompassing primary and secondary intelligence gathering. Expert interviews with platform developers, pharmaceutical R&D heads, and regulatory consultants provided firsthand perspectives on technological hurdles, validation requirements, and market drivers. Secondary sources included peer-reviewed journals, white papers from scientific societies, and public filings to triangulate industry trends and competitive positioning.

Segmentation and regional dynamics were examined through a bottom-up categorical analysis, mapping material types, device configurations, and end-user applications against geographic adoption patterns. Trade policy impacts were assessed using an overlay of tariff schedules and procurement data to identify shifts in sourcing strategies. Company intelligence integrated funding histories, partnership announcements, and patent filings to gauge innovation pipelines and strategic focus areas.

Throughout the research process, methodological rigor was maintained by cross-validating insights across multiple data points and employing a standardized validation checklist to ensure consistency. The resulting findings deliver an authoritative roadmap, equipping stakeholders with actionable intelligence to navigate the organs-on-chips landscape with confidence.

Bridging Insights to Future Horizons in Organ-on-Chip Research

The organs-on-chips sector stands at the cusp of mainstream integration, offering unprecedented opportunities to refine drug discovery and personalized medicine. The intersection of material innovation, microfabrication expertise, and data analytics continues to push the boundaries of physiological relevance, while evolving trade dynamics underscore the importance of resilient supply chains.

By understanding granular segmentation across materials, products, technologies, end users, applications, and organ types, decision-makers can identify niche opportunities and tailor go-to-market strategies. Regional insights highlight varying adoption catalysts-from regulatory incentives in Europe to manufacturing prowess in Asia-Pacific and collaborative ecosystems in the Americas-informing localization and partnership choices.

Industry leaders who prioritize co-development, harness AI-driven analytics, and engage proactively with standardization bodies will accelerate validation pathways and drive broader acceptance. As the market matures, a unified approach that blends scientific rigor with strategic agility will prove essential for capturing growth and delivering superior research outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Material
    • Glass
    • PDMS
    • Thermoplastics
  • Product
    • Consumables
      • Microplates
      • Reagents
    • Instruments
    • Software
  • Technology
    • Microfluidic Chips
      • Multi Layer Chips
      • Single Layer Chips
    • Multi Organ Chips
    • Single Organ Chips
  • End User
    • Academic Institutes
    • Biotechnology Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
      • Global Pharma
      • Specialty Pharma
  • Application
    • Disease Modeling
    • Drug Discovery
      • High Throughput Screening
      • Lead Optimization
    • Personalized Medicine
    • Toxicity Testing
  • Organ Type
    • Gut
    • Heart
    • Kidney
    • Liver
      • Hepatocyte Based
      • Spheroid Based
    • Lung
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Emulate, Inc.
  • MIMETAS B.V.
  • TissUse GmbH
  • CN Bio Innovations Ltd.
  • InSphero AG
  • Nortis, Inc.
  • Hµrel Corporation
  • Tara Biosystems, Inc.
  • AxoSim LLC
  • Kirkstall Ltd

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Organs-on-chips Market, by Material
8.1. Introduction
8.2. Glass
8.3. PDMS
8.4. Thermoplastics
9. Organs-on-chips Market, by Product
9.1. Introduction
9.2. Consumables
9.2.1. Microplates
9.2.2. Reagents
9.3. Instruments
9.4. Software
10. Organs-on-chips Market, by Technology
10.1. Introduction
10.2. Microfluidic Chips
10.2.1. Multi Layer Chips
10.2.2. Single Layer Chips
10.3. Multi Organ Chips
10.4. Single Organ Chips
11. Organs-on-chips Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
11.5.1. Global Pharma
11.5.2. Specialty Pharma
12. Organs-on-chips Market, by Application
12.1. Introduction
12.2. Disease Modeling
12.3. Drug Discovery
12.3.1. High Throughput Screening
12.3.2. Lead Optimization
12.4. Personalized Medicine
12.5. Toxicity Testing
13. Organs-on-chips Market, by Organ Type
13.1. Introduction
13.2. Gut
13.3. Heart
13.4. Kidney
13.5. Liver
13.5.1. Hepatocyte Based
13.5.2. Spheroid Based
13.6. Lung
14. Americas Organs-on-chips Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Organs-on-chips Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Organs-on-chips Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Emulate, Inc.
17.3.2. MIMETAS B.V.
17.3.3. TissUse GmbH
17.3.4. CN Bio Innovations Ltd.
17.3.5. InSphero AG
17.3.6. Nortis, Inc.
17.3.7. Hµrel Corporation
17.3.8. Tara Biosystems, Inc.
17.3.9. AxoSim LLC
17.3.10. Kirkstall Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ORGANS-ON-CHIPS MARKET MULTI-CURRENCY
FIGURE 2. ORGANS-ON-CHIPS MARKET MULTI-LANGUAGE
FIGURE 3. ORGANS-ON-CHIPS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ORGANS-ON-CHIPS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ORGANS-ON-CHIPS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ORGANS-ON-CHIPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PDMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MULTI LAYER CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY SINGLE LAYER CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY MULTI ORGAN CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY SINGLE ORGAN CHIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY GLOBAL PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY SPECIALTY PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY GUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY HEPATOCYTE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY SPHEROID BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ORGANS-ON-CHIPS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 74. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 76. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 78. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 80. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 82. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 158. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 160. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 173. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 174. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 176. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 178. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 180. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 182. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 183. ITALY ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 189. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 191. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 193. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 194. SPAIN ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 235. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 237. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 250. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 251. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 253. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 255. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 257. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 259. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 260. QATAR ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 264. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 266. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 268. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 270. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 294. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 295. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 297. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 299. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 301. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 303. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 304. EGYPT ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 306. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 308. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 310. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 312. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 314. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 315. TURKEY ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 327. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 328. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 329. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 330. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 331. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 332. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 334. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 336. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 337. NORWAY ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 338. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 339. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 340. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 341. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 343. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 345. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 347. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 348. POLAND ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 351. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 352. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 353. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY MICROFLUIDIC CHIPS, 2018-2030 (USD MILLION)
TABLE 354. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 356. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 357. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 358. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 359. SWITZERLAND ORGANS-ON-CHIPS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 360. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 361. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 362. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY CONSUMABLES, 2018-203

Companies Mentioned

The companies profiled in this Organs-on-chips market report include:
  • Emulate, Inc.
  • MIMETAS B.V.
  • TissUse GmbH
  • CN Bio Innovations Ltd.
  • InSphero AG
  • Nortis, Inc.
  • Hµrel Corporation
  • Tara Biosystems, Inc.
  • AxoSim LLC
  • Kirkstall Ltd

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 212.96 Million
Forecasted Market Value ( USD ) by 2030 $ 926.85 Million
Compound Annual Growth Rate34.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Organ-on-a-Chip Market Size, Share & Trends Analysis Report by Products & Service (Products, Service), Application (Drug Discovery, Toxicology Research), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Organ-on-a-Chip Market Size, Share & Trends Analysis Report by Products & Service (Products, Service), Application (Drug Discovery, Toxicology Research), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Organs-on-Chips Market Industry Trends and Global Forecasts to 2035, by Type of Product, Type of Organ, Type of Single Organ based Model, Type of Material of Construction, Purpose, Application Area, End User, Key Geographical Regions and Leading Players - Product Image

Organs-on-Chips Market Industry Trends and Global Forecasts to 2035, by Type of Product, Type of Organ, Type of Single Organ based Model, Type of Material of Construction, Purpose, Application Area, End User, Key Geographical Regions and Leading Players

  • Report
  • 218 Pages
  • Global
From
Organ-on-chip Market Report by Offering, Type, Application, End Use, and Region 2025-2033 - Product Image

Organ-on-chip Market Report by Offering, Type, Application, End Use, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From
Organs-on-Chips - Global Strategic Business Report - Product Image

Organs-on-Chips - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Organs on Chips Market 2024-2028 - Product Image

Organs on Chips Market 2024-2028

  • Report
  • 134 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.